Accordingly, retrospective bioinformatics analyses have linked high expression of survivin-ΔEx3 to unfavorable outcome in various patient series[26], further supporting the more general role of survivin as a poor prognostic marker in breast cancer[43]. This evidence concerns the gene BIRC5 and breast carcinoma.